The market is driven by rising incidence rates of adverse drug events, favorable government regulations and policies, and increasing approvals of new molecules and biosimilars
1h Free Analyst Time
The pharmacovigilance and drug safety software market is poised to grow by $72.74 million during 2022-2026, accelerating at a CAGR of 7.11% during the forecast period.Speak directly to the analyst to clarify any post sales queries you may have.
This report on the pharmacovigilance and drug safety software market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment.
The market is driven by rising incidence rates of adverse drug events, favorable government regulations and policies, and increasing approvals of new molecules and biosimilars.
The pharmacovigilance and drug safety software market analysis includes the end-user segment and geographic landscape.
The pharmacovigilance and drug safety software market is segmented as below:
By End-user
- Pharmaceutical and biotechnology companies
- Contract research organization
- Business process outsourcing
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The analyst presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. This report covers the following areas:
- Pharmacovigilance and drug safety software market sizing
- Pharmacovigilance and drug safety software market forecast
- Pharmacovigilance and drug safety software market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The analyst presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The analyst's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Five Forces Analysis
5 Market Segmentation by End-user
6 Customer Landscape
7 Geographic Landscape
8 Drivers, Challenges, and Trends
9 Vendor Landscape
10 Vendor Analysis
11 Appendix
List of Exhibits
Executive Summary
The analyst recognizes the following companies as the key players in the global pharmacovigilance and drug safety software market: AB Cube SARL, Accenture Plc, Advera Health Analytics Inc., ArisGlobal LLC, BaseCon AS, Clarivate PLC, Cognizant Technology Solutions Corp., Ennov, EXTEDO GmbH, Honeywell International Inc., Indegene Pvt. Ltd., IQVIA Holdings Inc., Max Application Srl, Oracle Corp., Pegasystems Inc., Sarjen Systems Pvt. Ltd., United BioSource LLC, Veeva Systems Inc., and Wipro Ltd.Commenting on the report, an analyst said: ''The latest trend gaining momentum in the market is integration of AI in pharmacovigilance.''
According to the report, one of the major drivers for this market is the rising incidence rates of adverse drug events.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned
A selection of companies mentioned in this report includes:
- AB Cube SARL
- Accenture PLC
- Advera Health Analytics Inc.
- ArisGlobal LLC
- BaseCon AS
- Clarivate PLC
- Cognizant Technology Solutions Corp.
- Ennov
- EXTEDO GmbH
- Honeywell International Inc.
- Indegene Pvt. Ltd.
- IQVIA Holdings Inc.
- Max Application Srl
- Oracle Corp.
- Pegasystems Inc.
- Sarjen Systems Pvt. Ltd.
- United BioSource LLC
- Veeva Systems Inc.
- Wipro Ltd.
